Editing Glanders (section)

==Vaccine research==
No vaccine is licensed for use in the U.S.<ref name="CDCprev" /> Infection with these bacteria results in nonspecific symptoms and can be either acute or chronic, impeding rapid diagnosis. The lack of a vaccine for either bacterium also makes them potential candidates for bioweaponization.<ref>{{Cite book |doi=10.1007/978-1-4419-1266-4_4 |chapter=Melioidosis and Glanders as Possible Biological Weapons |title=Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century |pages=99–145 |year=2009 |last1=Dance |first1=David Allan Brett |isbn=978-1-4419-1265-7}}</ref> Together, with their high rate of infectivity by aerosols and resistance to many common antibiotics, both bacteria have been classified as category B priority pathogens by the US NIH and US CDC, which has spurred a dramatic increase in interest in these microorganisms. Attempts have been made to develop vaccines for these infections, which would not only benefit military personnel, a group most likely to be targeted in an intentional release, but also individuals who may come in contact with glanders-infected animals or live in areas where melioidosis is endemic.